90% of patients respond to new blood cancer treatment in trial

Tue, 5 Sep 2023 19:22:53 +1000

Andrew Pam <xanni [at] glasswings.com.au>

Andrew Pam
https://www.freethink.com/health/multiple-myeloma-car-t

"A new cancer therapy developed at Jerusalem’s Hadassah-University Medical
Center had a 90% response rate in a new clinical trial, with over half of
patients going into total remission. The CAR-T therapy — which arms the body’s
own immune cells to fight cancer — was able to send multiple myeloma, an
extremely deadly cancer that impacts the immune system, into remission.

The therapy is the result of years worth of experiments conducted by the
hospital’s bone-marrow transplant and immunotherapy department, the Jerusalem
Post
 reported.

“We have evidence of a very positive overall response rate with minimal side
effects, and they are mild,” Polina Stepensky, the head of the bone marrow
transplantation and cancer immunotherapy department, told the Jerusalem Post.

“These are dramatic results. This is a huge hope for patients with a disease
that has not yet had a cure.”"

Via Future Crunch:
<https://futurecrunch.com/good-news-trachoma-human-rights-mexico-river-madrid-spain/>

Cheers,
       *** Xanni ***
--
mailto:xanni@xanadu.net               Andrew Pam
http://xanadu.com.au/                 Chief Scientist, Xanadu
https://glasswings.com.au/            Partner, Glass Wings
https://sericyb.com.au/               Manager, Serious Cybernetics

Comment via email

Home E-Mail Sponsors Index Search About Us